Administration is straightforward: subcutaneous injection with an insulin needle, once daily, self-administered at home
Its relevance in aging research makes it a key compound for studies exploring long-term cellular regulation and biological timekeeping systems
The peptide was first isolated during experiments in rabbits and named for its reported association with increased electroencephalographic delta activity
Most research-context protocols use 3.0 mL of bacteriostatic water for the 80 mg vial, which produces about 26.7 mg/mL total blend concentration
Vegan capsules with delayed release: the gastro-resistant capsule shell protects the active ingredients from stomach acid and ensures a delayed release in the intestine
Since BPC-157 has not completed formal Phase IIII clinical trials, data on long-term safety, immunogenicity, and adverse effects are unknown